NFKB1 and type 1 diabetes mellitus: Although, in vitro and in vivo models of T1D have shown that activation of the canonical NF-κB pathway in β-cells is generally deleterious [7], little is known regarding the role of the non-canonical NF-κB pathway in diabetes.